{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:50:14Z","timestamp":1762541414807},"reference-count":40,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,2,14]],"date-time":"2005-02-14T00:00:00Z","timestamp":1108339200000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Proton\u2010pump inhibitors, such as lansoprazole, are metabolized in the liver by CYP2C19 and cannot inhibit acid sufficiently in homozygous extensive metabolizers of CYP2C19.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To examine whether famotidine would increase the cure rates of <jats:italic>Helicobacter pylori<\/jats:italic> infection by a standard triple therapy.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002A total of 177 <jats:italic>H. pylori<\/jats:italic>\u2010positive patients were randomly assigned to either lansoprazole 30\u2003mg b.d., clarithromycin 200\u2003mg b.d. and amoxicillin 750\u2003mg b.d. for 1\u2003week (LCA group; <jats:italic>n<\/jats:italic>\u2003=\u200389) or famotidine 20\u2003mg b.d., lansoprazole 30\u2003mg b.d., clarithromycin 200\u2003mg b.d. and amoxicillin 750\u2003mg b.d. for 1\u2003week (FLCA group; <jats:italic>n<\/jats:italic>\u2003=\u200388). Famotidine was administered after lunch and before sleep, and the others were after breakfast and dinner. CYP2C19 genotypes were determined by a polymerase chain reaction restriction fragment length polymorphism (PCR\u2013RFLP) method.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002In the LCA group, the eradication rates for homozygous extensive metabolizers, heterozygous extensive metabolizers, and poor metabolizers were 63%, 87%, and 100%, respectively (<jats:italic>P<\/jats:italic>\u2003=\u20030.014). Those in the FLCA group were 85%, 85%, and 100%, respectively (N.S.). The cure rate for homozygous extensive metabolizers in the FLCA group was significantly higher than that in the LCA group (<jats:italic>P<\/jats:italic>\u2003= 0.035).<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> :\u2002Famotidine improves the cure rate of <jats:italic>H. pylori<\/jats:italic> infection by a triple therapy in CYP2C19 homozygous extensive metabolizers patients.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02353.x","type":"journal-article","created":{"date-parts":[[2005,2,15]],"date-time":"2005-02-15T01:24:43Z","timestamp":1108430683000},"page":"491-497","source":"Crossref","is-referenced-by-count":21,"title":["Concomitant dosing of famotidine with a triple therapy increases the cure rates of <i>Helicobacter pylori<\/i> infections in patients with the homozygous extensive metabolizer genotype of CYP2C19"],"prefix":"10.1111","volume":"21","author":[{"given":"K.","family":"Okudaira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,2,14]]},"reference":[{"key":"e_1_2_13_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07023-7"},{"key":"e_1_2_13_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-4-199702150-00004"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331508"},{"key":"e_1_2_13_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094541"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04310.x"},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199007000-00020"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90004-1"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280100342"},{"key":"e_1_2_13_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90137-5"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03256.x"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199631010-00002"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-12-199812150-00006"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70075-5"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.106826"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200106000-00009"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(03)00288-X"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113959"},{"key":"e_1_2_13_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01108.x"},{"key":"e_1_2_13_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01229.x"},{"key":"e_1_2_13_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01050.x"},{"key":"e_1_2_13_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01962615"},{"key":"e_1_2_13_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.30.1.192-200.1992"},{"key":"e_1_2_13_26_2","first-page":"594","article-title":"Identification of a new genetic defect responsible for the polymorphism of (S)\u2010mephenytoin metabolism in Japanese","volume":"46","author":"De Morais SM","year":"1994","journal-title":"Mol Pharmacol"},{"key":"e_1_2_13_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)40694-6"},{"key":"e_1_2_13_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90214-3"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01963775"},{"key":"e_1_2_13_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.2008.S56"},{"key":"e_1_2_13_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8690200"},{"key":"e_1_2_13_32_2","first-page":"80","article-title":"Sufficient effect of 1\u2010week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P4502C19 poor metabolizers","volume":"34","author":"Aoyama N","year":"1999","journal-title":"J Gastroenterol"},{"key":"e_1_2_13_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07427.x"},{"key":"e_1_2_13_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70017-2"},{"key":"e_1_2_13_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(01)28055-2"},{"key":"e_1_2_13_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31876"},{"key":"e_1_2_13_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199807000-00010"},{"key":"e_1_2_13_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00563.x"},{"key":"e_1_2_13_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.54196000.x"},{"key":"e_1_2_13_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.24.4.270"},{"key":"e_1_2_13_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199506002-00004"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02353.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02353.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:08:38Z","timestamp":1697231318000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02353.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02353.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02353.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}